Assessment of Left Ventricular Systolic Function by Echocardiography

Heart Failure Clinics

Volumn 5, Issue 2, 2009, Pages 177-190

  St John Sutton, Martin G ^a   Plappert, Ted ^a   Rahmouni, Hind ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Echocardiography; Heart failure; Remodeling; Systolic function

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CLINICAL ASSESSMENT; CLINICAL FEATURE; DIASTOLIC HEART FAILURE; DRUG EFFICACY; ECHOCARDIOGRAPHY; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VOLUME; HUMAN; MITRAL VALVE REGURGITATION; PREVALENCE; QUALITY OF LIFE; REVIEW; SYSTOLIC HEART FAILURE; WALL STRESS;

DILATATION, PATHOLOGIC; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; HEART FAILURE; HEART VENTRICLES; HUMANS; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL CONTRACTION; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 60749125811     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2008.11.010     Document Type: Review

References (39)

1. Vasan R.S., and Levy D. Defining diastolic HF: a call for standardized diagnostic criteria. Circulation 101 (2000) 2118-2121
2. Zile M.R., Gaasch W.H., Carroll J.D., et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic HF?. Circulation 104 (2001) 779-782
3. Kitzman D.W., Gardin J.M., Gottdiener J.S., et al. Importance of HF with preserved systolic function in patients >65 years of age. Am J Cardiol 87 (2001) 413-419
4. Smith G.L., Masoudi F.A., Vaccarino V., et al. Outcomes in HF patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 41 (2003) 1510-1518
5. Grossman W., Jones D., and McLaurin L.P. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56 (1975) 14-23
6. Reichek N., Wilson J.R., St. John Sutton M., et al. Non-invasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation 65 (1982) 99-108
7. Gerdts E., Zabalgoitia M., Bjornstad H., et al. Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). Am J Cardiol 87 (2001) 980-983
8. Devereux R.B., Roman M.J., de Simone G., et al. Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study. Circulation 96 (1997) 1416-1423
9. Devereux R.B., Bella J.N., Palmieri V., et al. Left ventricular systolic dysfunction in a biracial sample of hypertensive adults: The Hypertension Genetic Epidemiology Network (Hyper GEN) Study. Hypertension 38 (2001) 417-423
10. Lang R.M., Bierig M., Devereux R.B., et al. A report from the American Society of Echocardiography's Nomenclature and Standards Committee and the Task Force on Chamber Quantification, developed in conjunction with the American College of Cardiology Echocardiography Committee, the American Heart Association, and the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
11. St John Sutton M., Otterstat J.E., Plappert T., et al. Quantitaion of Left Ventricular Volumes and Ejection Fraction in Post-infarction Patients from Biplane and Single Plane Two Dimensional Echocardiograms. A Prospective Longitudinal Study of 1113 Echocardiograms. Eur Heart J 19 (1998) 808-816
12. St. John Sutton M., and Plappert T. Core lab, no core lab or automated LVEF?. Eur J Echocardiogr 8 (2007) 239-240
13. Cannesson M., Tanabe M., Suffoletto M.S., et al. A novel two-dimensional echocardiographic image analysis system using artificial intelligence-learned pattern recognition for rapid automated ejection fraction. J Am Coll Cardiol 49 (2007) 217-226
14. Rahmouni H.W., Ky B., Plappert T., et al. Clinical utility of automated assessment of left ventricular ejection fraction using artificial intelligence-assisted border detection. Am Heart J 155 (2008) 562-570
15. Mor-Avi V., Sugeng L., Weinert L., et al. Fast measurement of left ventricular mass with real-time three-dimensional echocardiography: comparison with magnetic resonance imaging. Circulation 110 (2004) 1814-1818
16. St. John Sutton M., Pfeffer M.A., Plappert T., et al. Quantitative two dimensional echocardiographic measurements are major predictors of adverse cardiovascular events following acute myocardial infarction: the protective effects of captopril. Circulation 89 (1994) 68-75
17. White H.D., Norris R.M., Brown M.A., et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76 (1987) 44-51
18. St. John Sutton M., Lee D., Rouleau J.L., et al. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation 107 (2003) 2577-2582
19. St John Sutton M., Pfeffer M.A., Moye L.A., et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril. Information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation 96 (1997) 3294-3300
20. Lamas G.A., Vaughan D.E., Parisi A.F., et al. Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction. Am J Cardiol 63 (1989) 1167-1173
21. Pfeffer M.A., Braunwald E., Moyé L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327 (1992) 669-677
22. The SOLVD Investigators. Effect of enalapril on mortality and the development of HF in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327 (1992) 685-691
23. Bristow M.R., Krause-Steinrauf H., Nuzzo R., et al. Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial. Circulation 110 (2004) 1437-1442
24. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic HF. N Engl J Med 346 (2002) 1845-1853
25. Mann D.L., Acker M.A., Jessup M., and Acorn Trial Principal Investigators and Study Coordinators. Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Ann Thorac Surg 84 4 (2007) 1226-1235
26. Aurigemma G.P., Zile M.R., and Gaasch W.H. Contractile behavior of the left ventricle in diastolic heart failure: with emphasis on regional systolic function. Circulation 113 (2006) 296-304
27. Sutherland G.R., Stewart M.J., Groundstroem K.W., et al. Color Doppler myocardial imaging: a new technique for the assessment of myocardial function. J Am Soc Echocardiogr 7 (1994) 441-458
28. Edvardsen T., Skulstad H., Urheim S., et al. Regional myocardial function during acute myocardial ischemia assessed by strain Doppler echocardiography. J Am Coll Cardiol 37 (2001) 726-730
29. Abraham T.P., and Nishimura R.A. Myocardial strain: can we finally measure contractility?. J Am Coll Cardiol 37 (2001) 731-734
30. Gotte M.J.W., van Rossum A.C., Twisk J.W.R., et al. Quantication of regional contractile function after infarction: strain analysis superior to wall thickening analysis in discriminating infarct from remote myocardium. J Am Coll Cardiol 37 (2001) 808-817
31. Korineck J., Wang J., Sengupta P.P., et al. Two-dimensional strain-A Doppler independent ultrasound method for quantitation of regional deformation: validation in vitro and in vivo. J Am Soc Echocardiogr 18 (2005) 1247-1253
32. Artis N.J., Oxborough D.L., Williams G., et al. Two-dimensional strain imaging: a new echocardiographic advance with research and clinical applications. Int J Cardiol 123 (2008) 240-248
33. Senzaki H., Chen C.-H., and Kass D.A. Singe beat estimation of end-systolic pressure-volume relation in humans: a new method with the potential for non-invasive application. Circulation 94 (1996) 2497-2506
34. Grigioni F., Enriquez-Sarano M., Zehr K.J., et al. Regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103 (2001) 1759-1764
35. St John Sutton M.G., Plappert T., Abraham W.T., et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic HF. Circulation 107 (2003) 1985-1990
36. Linde C., Gold M.R., Abraham W.T., et al. Randomized trial of cardiac resynchronization in mildly symptomatic HF patients and in asymptomatic patients with left ventricular dysfunction and previous HF symptoms. J Am Coll Cardiol (2008) in press
37. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in HF. N Engl J Med 352 (2005) 1539-1549
38. Yu C., Chau E., Sanderson J.E., et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in HF. Circulation 105 (2002) 438-445
39. Chung E.S., Leon A.R., Tavazzi L., et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 117 (2008) 2608-2616